KENALOG-10 Drug Patent Profile
✉ Email this page to a colleague
When do Kenalog-10 patents expire, and what generic alternatives are available?
Kenalog-10 is a drug marketed by Apothecon and is included in one NDA.
The generic ingredient in KENALOG-10 is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Kenalog-10
A generic version of KENALOG-10 was approved as triamcinolone acetonide by TARO on October 1st, 1986.
Summary for KENALOG-10
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 82 |
Clinical Trials: | 78 |
Patent Applications: | 4,715 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for KENALOG-10 |
What excipients (inactive ingredients) are in KENALOG-10? | KENALOG-10 excipients list |
DailyMed Link: | KENALOG-10 at DailyMed |
Recent Clinical Trials for KENALOG-10
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Foundation for Orthopaedic Research and Education | Phase 1 |
Florida Orthopaedic Institute | Phase 1 |
Next Generation Regenerative Medicine LLC | Phase 1/Phase 2 |
Pharmacology for KENALOG-10
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for KENALOG-10
US Patents and Regulatory Information for KENALOG-10
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apothecon | KENALOG-10 | triamcinolone acetonide | INJECTABLE;INJECTION | 012041-001 | Approved Prior to Jan 1, 1982 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |